Triveni Bio · Watertown, MA, US
· Posted 2026-10-28
· 5+ years
COMPANY INTRODUCTION Triveni Bio is breaking new ground in the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine. We are pioneering a Mendelian genetics-informed precision medicine approach to develop functional antibodies for t
R
Triveni Bio · Watertown, MA, US
· Posted 2026-10-12
· 8+ years
COMPANY INTRODUCTION Triveni Bio is breaking new ground in the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine. We are pioneering a Mendelian genetics-informed precision medicine approach to develop functional antibodies for t
Directorsupportensureinitiativesoperationsvendorsaccessetc
Triveni Bio · Watertown, MA, US
· Posted 2026-10-02
· 5+ years
COMPANY INTRODUCTION Triveni Bio is breaking new ground in the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine. We are pioneering a Mendelian genetics-informed precision medicine approach to develop functional antibodies for t
ScientistTranslationalResearchbiomarkerdesignleadbiologyanalyses
Triveni Bio · Watertown, MA, US
· Posted 2026-09-15
· 8+ years
COMPANY INTRODUCTION Triveni Bio is breaking new ground in the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine. We are pioneering a Mendelian genetics-informed precision medicine approach to develop functional antibodies for t
DirectorClinicalDevelopmentregulatorymedicalscientificsafetyprogram
Triveni Bio · Watertown, MA, US
· Posted 2026-03-18
· 2+ years
COMPANY INTRODUCTION Triveni Bio is breaking new ground in the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine. We are pioneering a Mendelian genetics-informed precision medicine approach to develop functional antibodies for t
GCP